Osteopontin is a useful predictor of bone metastasis and survival in patients with locally advanced nasopharyngeal carcinoma. (Q48208750)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25824984%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

title

Osteopontin is a useful predictor of bone metastasis and survival in patients with locally advanced nasopharyngeal carcinoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25824984%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25824984%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

author name string

Xue Hou

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25824984%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Xuan Wu

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25824984%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Peiyu Huang

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25824984%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Jianhua Zhan

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25824984%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Ting Zhou

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25824984%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Yuxiang Ma

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25824984%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Tao Qin

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25824984%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Rongzhen Luo

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25824984%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Yanfen Feng

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25824984%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Ying Xu

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25824984%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Likun Chen

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25824984%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

language of work or name

English

0 references

publication date

29 April 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25824984%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Cancer

4 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25824984%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

volume

137

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25824984%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25824984%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

page(s)

1672-1678

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25824984%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

cites work

Global cancer statistics

1 reference

Nasopharyngeal carcinoma: the next challenges

21 January 2018

1 reference

International patterns of cancer incidence in adolescents.

21 January 2018

1 reference

Current management of nasopharyngeal cancer.

21 January 2018

1 reference

Intensity-modulated radiation therapy (IMRT) for nasopharynx cancer: update of the Memorial Sloan-Kettering experience

21 January 2018

1 reference

Treatment results for nasopharyngeal carcinoma in the modern era: the Hong Kong experience.

21 January 2018

1 reference

Small integrin-binding ligand N-linked glycoproteins (SIBLINGs): multifunctional proteins in cancer

21 January 2018

1 reference

Serum osteopontin, an enhancer of tumor metastasis to bone, promotes B16 melanoma cell migration

21 January 2018

1 reference

Bone sialoprotein is predictive of bone metastases in resectable non-small-cell lung cancer: a retrospective case-control study

21 January 2018

1 reference

Bone sialoprotein, matrix metalloproteinase 2, and alpha(v)beta3 integrin in osteotropic cancer cell invasion.

21 January 2018

1 reference

Expression of bone sialoprotein and osteopontin in breast cancer bone metastases

21 January 2018

1 reference

Predictive significance of bone sialoprotein and osteopontin for bone metastases in resected Chinese non-small-cell lung cancer patients: a large cohort retrospective study

21 January 2018

1 reference

Different clinical significance of pre- and post-treatment plasma Epstein-Barr virus DNA load in nasopharyngeal carcinoma treated with radiotherapy

21 January 2018

1 reference

BSP and RANKL induce osteoclastogenesis and bone resorption synergistically

21 January 2018

1 reference

Enhanced cell surface CD44 variant (v6, v9) expression by osteopontin in breast cancer epithelial cells facilitates tumor cell migration: novel post-transcriptional, post-translational regulation

21 January 2018

1 reference

Transfection of MDA-MB-231 human breast carcinoma cells with bone sialoprotein (BSP) stimulates migration and invasion in vitro and growth of primary and secondary tumors in nude mice

21 January 2018

1 reference

Osteopontin overexpression in breast cancer: knowledge gained and possible implications for clinical management.

21 January 2018

1 reference

Low dentin matrix protein 1 expression correlates with skeletal metastases development in breast cancer patients and enhances cell migratory capacity in vitro

21 January 2018

1 reference

Differential expression of osteopontin and bone sialoprotein in bone metastasis of breast and prostate carcinoma

21 January 2018

1 reference

Increased expression of osteopontin contributes to the progression of prostate cancer

21 January 2018

1 reference

Osteopontin induces AP-1-mediated secretion of urokinase-type plasminogen activator through c-Src-dependent epidermal growth factor receptor transactivation in breast cancer cells

21 January 2018

1 reference

Abrogation of the interaction between osteopontin and alphavbeta3 integrin reduces tumor growth of human lung cancer cells in mice.

21 January 2018

1 reference

Inhibition of osteopontin would suppress angiogenesis in gastric cancer

21 January 2018

1 reference

A multigenic program mediating breast cancer metastasis to bone

21 January 2018

1 reference

Osteopontin: an effector and an effect of tumor metastasis.

21 January 2018

1 reference

Osteopontin, a novel substrate for matrix metalloproteinase-3 (stromelysin-1) and matrix metalloproteinase-7 (matrilysin).

21 January 2018

1 reference

Osteopontin deficiency produces osteoclast dysfunction due to reduced CD44 surface expression

21 January 2018

1 reference

Expression of bone sialoprotein in primary human breast cancer is associated with poor survival

21 January 2018

1 reference

Prognostic value of bone sialoprotein expression in clinically localized human prostate cancer

21 January 2018

1 reference

Adjuvant zoledronic acid in patients with early breast cancer: final efficacy analysis of the AZURE (BIG 01/04) randomised open-label phase 3 trial

21 January 2018

1 reference